Special items: Ovarian Cancer and Us blog best viewed in Firefox

Monday, February 08, 2010

Marshall Edwards, Inc. Announces Resignation of Christopher Naughton From Board of Directors

Note: the OVATURE ovarian cancer trial results are to be published later this year - Phenoxodiol

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.